Safety and Efficacy of antiviral drugs against covid-19 infection: an updated systemic review

AMR Al-juhaishi, ND Aziz - Medical and Pharmaceutical Journal, 2022 - pharmacoj.com
SARS-CoV-2 infection is an acute pneumonia attack caused by a largely-infectious, recently
elicited, and murdered virus with global public health issues and economic problems. Many …

Safety and efficacy of antiviral drugs for the treatment of COVID-19: a systematic review

Z Nie, T Sun, F Zhao - Infection and Drug Resistance, 2022 - Taylor & Francis
Objective To investigate the efficacy and safety of antiviral drugs in the treatment of
coronavirus disease 2019 (COVID-19). Methods All clinical trials of antiviral drug treatment …

[HTML][HTML] Antiviral drugs and their roles in the treatment of coronavirus infection

R Alsafi, S Alghamdi, M Asif - Antiviral Drugs-Intervention …, 2022 - intechopen.com
Viruses are the major pathogenic agents that cause various diseases. Antiviral drugs are
used for the treatment of viral infections. Emergent advances of antiviral drugs are focused …

[PDF][PDF] Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.

F Rommasi, MJ Nasiri, M Mirsaiedi - European Review for …, 2021 - researchgate.net
OBJECTIVE: As a beta-coronavirus, Coronavirus disease-2019 (COVID-19) has caused one
of the most significant historical pandemics, as well as various health and medical …

[HTML][HTML] Antiviral treatment in COVID-19: which is the most promising?—a narrative review

AK Yadav, S Wen, X Xu, L Yu - Annals of Palliative Medicine, 2021 - apm.amegroups.org
The whole world is battling through coronavirus disease 2019 (COVID-19) which is a fatal
pandemic. In the early 2020, the World Health Organization (WHO) declared it as a global …

[HTML][HTML] Antiviral therapy in management of COVID-19: a systematic review on current evidence

M Yousefifard, A Zali, KM Ali… - Archives of academic …, 2020 - ncbi.nlm.nih.gov
Background: The purpose of the current systematic review is to evaluate the efficacy of
antiviral therapies in treatment of COVID-19. In addition, clinical trials on the efficacy of …

Current perspective of antiviral strategies against COVID-19

BA Ahidjo, MWC Loe, YL Ng, CK Mok… - ACS infectious …, 2020 - ACS Publications
COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …

Investigational antiviral drugs for the treatment of COVID-19 patients

S Beheshtirouy, E Khani, S Khiali, T Entezari-Maleki - Archives of Virology, 2022 - Springer
In the current pandemic of coronavirus disease 2019 (COVID-19), antiviral drugs are at the
center of attention because of their critical role against severe acute respiratory disease …

Antiviral agents for the treatment of COVID-19: Progress and challenges

M Singh, E de Wit - Cell Reports Medicine, 2022 - cell.com
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …

Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis

W Liu, P Zhou, K Chen, Z Ye, F Liu, X Li, N He, Z Wu… - Cmaj, 2020 - Can Med Assoc
BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …